Noopept

Supplements · Nootropics · Supplement, Typed Supps

A lab-made brain compound from Russia, studied mostly in patients with brain injuries or vascular disease — not in healthy people, and it’s not actually allowed to be sold as a US supplement.

Stage by stage

Intake (Tablet or capsule): Taken orally in small milligram doses.
Absorption (Gut): Absorbed relatively quickly based on available data.
Bloodstream (Circulates): Crosses into the brain, based on animal pharmacokinetic studies.
Brain (Proposed receptor activity): Proposed to act on memory-related receptor systems, based mostly on animal research.

What the evidence supports

Improving cognitive symptoms in patients with mild cognitive disorders from vascular or traumatic brain injury — limited evidence. A Russian comparative trial (20mg/day for about 8 weeks) found noopept at least as effective as piracetam, with some subgroup advantages. This is real human data, but it comes from a small, older, Russian-language trial in impaired patients, not a large modern placebo-controlled trial in the healthy adults most supplement users actually are.
Enhancing focus or memory in healthy adults — insufficient evidence. There is essentially no quality human trial evidence for cognitive enhancement in healthy people — what exists is almost entirely animal data or anecdotal user reports.
Evidence on US regulatory status as a dietary supplement — insufficient evidence. The FDA has issued warning letters stating noopept is not a legal dietary supplement ingredient in the US and is not generally recognized as safe and effective (GRASE) for any use — it also isn't an approved drug here, leaving it in an unregulated gray zone with no long-term human safety database.

Typical dose

Russian clinical trials used 20mg/day (10mg twice daily); informal use commonly ranges from 10–30mg/day, but there is no standardized or regulator-validated human dosing.

Upper limit: No established UL

Timing

No validated timing guidance exists given the limited human data.

Time to effect

Unclear: The small Russian clinical trials that exist assessed outcomes at roughly 8 weeks in impaired patients, not healthy adults.

Common myth

“Noopept is a well-studied, FDA-recognized nootropic supplement.” In reality: The FDA has stated noopept does not qualify as a legal dietary supplement ingredient in the US and is not an approved drug either — the human evidence that exists is real but limited to small, dated Russian trials in patients with brain injury or vascular disease.